Literature DB >> 25203288

Electroconvulsive therapy and its association with demographic and clinical characteristics in Chinese psychiatric patients.

Zhi-Min Wang1, Hui Zhu, Yan-Li Pan, Helen F K Chiu, Christoph U Correll, Gabor S Ungvari, Kelly Y C Lai, Xiao-Lan Cao, Yan Li, Bao-Liang Zhong, Xiang-Yang Zhang, Yu-Tao Xiang.   

Abstract

PURPOSE: Little is known about the frequency of electroconvulsive therapy (ECT) use in China. This study examined the frequency of ECT and its relationship with demographic and clinical characteristics in a large psychiatric institution in China.
METHODS: This was a retrospective chart review of all the 19,982 inpatients aged 18 to 59 years treated during the period of 8 years (2007-2013) in a tertiary psychiatric institution in Beijing. Sociodemographic and clinical data were collected from the electronic chart management system for discharged patients.
RESULTS: The frequency of ECT use was 57.7% in the whole sample, 68.4% in bipolar disorders, 66.3% in major depression, 55.2% in schizophrenia, and 28.6% in other psychiatric disorders. Patients who received ECT (ECT group) had shorter length of hospitalization compared with the non-ECT group. In multiple logistic regression analysis, ECT use was independently associated with age younger than 30 years; higher risk for suicide and aggression at time of admission; mood disorders; lower risk for falls; more treatment with antipsychotics, mood stabilizers, and antidepressants; less health insurance coverage and major medical conditions; as well as non-local residency status. Compared with 2007 (35.5%), ECT use significantly increased in the period of 2008 (49.1%) to 2013 (61.9%). All these significant correlates combined explained 20% of the variance of ECT use (P < 0.001).
CONCLUSIONS: In a major psychiatric center in China, the use of ECT was much more common than the figures reported from most countries around the world. Reasons for this difference and variances in outcomes between settings with higher and lower ECT use should be studied.

Entities:  

Mesh:

Year:  2015        PMID: 25203288     DOI: 10.1097/YCT.0000000000000181

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  6 in total

1.  Electroconvulsive practice in Singapore: a cross-sectional national survey.

Authors:  Phern-Chern Tor; Verònica Gálvez; Aaron Ang; Johnson Fam; Herng-Nieng Chan; Sheng-Neng Tan; Colleen K Loo
Journal:  Singapore Med J       Date:  2019-06-14       Impact factor: 1.858

2.  Electroconvulsive Therapy at a Veterans Health Administration Medical Center.

Authors:  Samuel T Wilkinson; Robert A Rosenheck
Journal:  J ECT       Date:  2017-12       Impact factor: 3.635

3.  Use of electroconvulsive therapy in adolescents with schizophrenia in China.

Authors:  Shuai Wang; Chao Yang; Junpu Jia; Yuming Zhou; Yi Zheng
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2018-12-05       Impact factor: 3.033

4.  Study protocol for a parallel-group, double-blinded, randomized, controlled, noninferiority trial: the effect and safety of hybrid electroconvulsive therapy (Hybrid-ECT) compared with routine electroconvulsive therapy in patients with depression.

Authors:  Han Rong; Shu-Xian Xu; Jing Zeng; Ying-Jia Yang; Jie Zhao; Wen-Tao Lai; Li-Chang Chen; Wen-Feng Deng; Xiangyang Zhang; Ying-Li Zhang; Min-Zhi Li; Li Xiao; Xin-Hui Xie
Journal:  BMC Psychiatry       Date:  2019-11-06       Impact factor: 3.630

5.  Demographic and Clinical Profile of Patients Receiving Electroconvulsive Therapy at a Tertiary Care Hospital in Oman: A Cluster Analysis.

Authors:  Alkhatib Al Saadi; Moon Fai Chan; Said Al-Kaabi; Mohamed Al Shukaili; Fatma Al-Mamari; Marwa Al Abdali; Zakariya Al Fazari; Salim Al-Huseini
Journal:  Oman Med J       Date:  2022-07-31

Review 6.  The impact of social, national and community-based health insurance on health care utilization for mental, neurological and substance-use disorders in low- and middle-income countries: a systematic review.

Authors:  Sumaiyah Docrat; Donela Besada; Susan Cleary; Crick Lund
Journal:  Health Econ Rev       Date:  2020-04-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.